Celltissue Res
In preclinical models, BPC-157 has been investigated for its influence on angiogenic signaling, nitric-oxidelinked pathways, and fibroblast activity associated with tendon and ligament biology [1][6][11]
Considerations for Clinical Adoption: Evidence, Safety, and Regulatory Landscape Despite encouraging preclinical findings and increasing patient enthusiasm, the integration of peptide-based therapies in mainstream orthopaedic practice remains cautious
BPC-157 has been studied for its influence on angiogenesis, nitric oxide signaling, and fibroblast activity, while TB-500 has been researched for its role in actin regulation, cell migration, and wound-healing processes
Daily injections can feel burdensome, especially when results are modest